LMR Partners’s Cabaletta Bio CABA Stock Holding History

LMR Partners’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-13,422	Closed	-$111K	–	925
2023 Q1	$111K	Buy	+13,422	New	+$126K	﹤0.01%	927

Other funds holding CABA

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LMR Partners's CABA Position: Q2 2023 in Review

LMR Partners sold out of Cabaletta Bio (CABA) in Q2 2023, closing a stake of 13,422 shares — an estimated $111K sold.

LMR Partners first reported a position in CABA in Q1 2023 and held it in 1 quarter. The position peaked at $111K in Q1 2023. 84 funds tracked by Wall St. Rank hold CABA as of Q2 2023.

LMR Partners reported no remaining Cabaletta Bio position as of Q2 2023 after selling out during the quarter.
LMR Partners sold 13,422 Cabaletta Bio shares in Q2 2023, an estimated $111K.
LMR Partners first reported a position in Cabaletta Bio in Q1 2023 and held it in 1 quarter.
LMR Partners's Cabaletta Bio position peaked at $111K in Q1 2023.
84 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2023.

Based on LMR Partners's 13F filing for Q2 2023, filed 14 Aug 2023.